As we barrel into the second half of the year, it’s time to look back and make sense of what just happened. Download our infographic for a quick, data-packed overview of the biopharma and medtech landscape in H1. From M&A activity to IPO hopefuls, venture financing disparity to stock price winners and losers – it’s all in there.  



Are companies in the mood to merge again?
How did dealmaking pan out in H1?
IPOs: signs of recovery or just wishful thinking?
Venture financing: growing gap between the cash-rich and the rest?